Show Notes
In this episode, MassDevice Editor Chris Newmarker talks with Alan Cheng, MD, chief medical officer at Medtronic’s cardiac rhythm management business about the future of medical-grade cardiac monitors like Medtronic LINQ monitors.
These tiny devices, placed just under the skin, can collect heart rhythm data and transmit it directly to doctors, like Cheng, who is a practicing electrophysiologist. The LINQ II has a battery life of more than four years. How does its functionality compare to consumer monitors, and can LINQ someday find a role as a health tracking tool sold over the counter?
Thank you to Resonetics for sponsoring this podcast episode. To learn more about how Resonetics supports medical device companies, visit: https://shorturl.at/E1wO8
In our FOMO interview, Jim Hammerand, managing editor of medical design and outsourcing, talks with Ken Charhut, CEO of Foldax about that start-ups innovative heart valve polymer and manufacturing process.
But we kick things off with this week’s Newmarker’s Newsmakers discussion with Host Tom Salemi and Chris Newmarker.
***
Enjoy the show? Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode. Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe
Chapters
- (00:04:30) - #5 - Surgical robotics market will double over the rest of the decade
- (00:07:23) - #4 - CMS adds reimbursement for cardiac ablation in ASCs
- (00:09:14) - #3 - Former Stryker robotics leader named CEO at Olympus' Swan EndoSurgical robotics play and Stryker promotes Spencer Stiles to president, COO
- (00:13:49) - #2 - Medtronic gets FDA nod for Hugo surgical robot in urologic procedures
- (00:16:35) - #1 - Johnson & Johnson MedTech to shift to business unit-led structure in 2026
- (00:20:18) - Interview with Eric Veit, Vice President, Nitinol Business Development, Resonetics
- (00:23:15) - FOMO – Ken Charhut, CEO, Foldax
- (00:33:48) - Keynote interview Alan Cheng, MD, chief medical officer, CRM, Medtronic
- (00:46:25) - Conclusion - Interview with Eric Veit, Vice President, Nitinol Business Development, Resonetics